Fertility outcomes in male adults with congenital hypogonadotropic hypogonadism treated during puberty with human chorionic gonadotropin and recombinant follicle stimulating hormone
Journal of Paediatrics and Child Health · 2024
DOI: 10.1111/jpc.16540 ↗At a glance
Journal article in Journal of Paediatrics and Child Health, 2024. Written by Francisca Grob and 3 co-authors. Institution: Department of Endocrinology, The Royal Children's Hospital, Melbourne, Victoria, Australia. Major MEDLINE topics: Chorionic Gonadotropin, Hypogonadism. Cited 9 times so far (Crossref); 12 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Aim
Hormone replacement therapy with testosterone for pubertal induction in boys with congenital hypogonadotropic hypogonadism (CHH) achieves virilization but not spermatogenesis. By contrast, human chorionic gonadotropin (hCG) and recombinant follicle stimulating hormone (rFSH) provides both virilization and spermatogenesis. Fertility outcomes of boys treated with recombinant therapy during adolescence have been infrequently described. We report fertility induction and pregnancy outcomes in CHH patients treated with recombinant gonadotropins during puberty.
Methods
Data of six subjects with CHH ( n = 3 Kallmann syndrome & n = 3 Isolated hypogonadotropic hypogonadism) treated with hCG and FSH for pubertal induction were reviewed. Of these, five underwent subsequent fertility induction while one desired fertility at the end of pubertal induction.
Results
Partners of all subjects achieved pregnancies using hCG and rFSH, all with full term live births. All infants were clinically normal.
Conclusion
This study provides early evidence of proof of concept of use of gonadotropin induction of puberty being beneficial in subsequent fertility outcome.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Endocrinology, The Royal Children's Hospital, Melbourne, Victoria, Australia.
- Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
- Division of Paediatrics, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
- Department of Pediatrics, Surya Hospital, Mumbai, India.
ORCID profiles: Francisca Grob
Cite
APA
Grob, F., Keshwani, R., Angley, E., & Zacharin, M. (2024). Fertility outcomes in male adults with congenital hypogonadotropic hypogonadism treated during puberty with human chorionic gonadotropin and recombinant follicle stimulating hormone. Journal of Paediatrics and Child Health. https://doi.org/10.1111/jpc.16540
Vancouver
Grob F, Keshwani R, Angley E, Zacharin M. Fertility outcomes in male adults with congenital hypogonadotropic hypogonadism treated during puberty with human chorionic gonadotropin and recombinant follicle stimulating hormone. Journal of Paediatrics and Child Health. 2024. doi:10.1111/jpc.16540
BibTeX
@article{Grob2024,
author = {Grob, Francisca and Keshwani, Rachna and Angley, Eleanor and Zacharin, Margaret},
title = {Fertility outcomes in male adults with congenital hypogonadotropic hypogonadism treated during puberty with human chorionic gonadotropin and recombinant follicle stimulating hormone},
journal = {Journal of Paediatrics and Child Health},
year = {2024},
doi = {10.1111/jpc.16540}
}
EUVIMED